ESC Premium Access

The role of right ventricular-arterial coupling in cardiac amyloidosis: a comparison between subtypes and with other genetic and non-genetic hypertrophic cardiomyopathies and prognostic consequences

Presentation

About the speaker

Doctor Giuseppe Palmiero

AORN Ospedali dei Colli - Monaldi Hospital, Naples (Italy)
0 follower

93 more presentations in this session

Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy

Speaker: Doctor D. Lawin (Bielefeld, DE)

Thumbnail

Cardiac rupture - the most serious complication of takotsubo syndrome

Speaker: Doctor M. Zalewska-Adamiec (Bialystok, PL)

Thumbnail

Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Trongtorsak (Evanston, US)

Thumbnail

Access the full session

Myocardial and pericardial disease e-posters

Speakers: Doctor G. Palmiero, Professor O. Blagova, Doctor D. Lawin, Doctor M. Zalewska-Adamiec, Professor O. Blagova...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.

27 August 2021

ESC Premium Access

Estimating treatment effect of tafamidis on hospitalisation in NYHA class III ATTR-CM patients in the presence of death using principal stratification

27 August 2021

ESC Premium Access

Exploration of electrocardiographic and echocardiographic findings to screen transthyretin amyloid cardiomyopathy in patients with mild left ventricular hypertrophy

27 August 2021

This platform is supported by

logo Novo Nordisk